Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.

NCT01927939 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01927939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01927939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2012
Completion date
August 31, 2014
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

18f-fdg pet, breast cancer